About Index Trending news
Analyze
Pricing
Amgen Inc.

Amgen Inc.

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Investment profile

Target markets
Biotechnology

Activity

Past year's investments

- Amgen Ventures participated in 3 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $275,000,000 (averaging $91,666,667 per round).

Latest rounds

- WuXi NextCODE: Venture capital (Series B) ($240M)
- GNS Healthcare: Venture capital (Series C) ($6M)
- Science 37: Venture capital (Series C) ($29M)

Main Co-investors

- Domain Associates
- MPM Capital
- DAG Ventures

Total funding
$66.5M in 3 rounds from 12 investors
By Amgen Ventures
$29M Series C in Apr, 2017
Total funding
$42.4M in 2 rounds from 5 investors
By Amgen Ventures
$11.9M Series B in Jul, 2016
Total funding
$36.7M in 6 rounds from 13 investors
By Amgen Ventures
$6M Series C in Aug, 2017
Total funding
$330M in 3 rounds from 9 investors
By Amgen Ventures
$240M Series B in Sep, 2017
Total funding
$60.5M in 4 rounds from 18 investors
By Amgen Ventures
$8.5M Series C in Feb, 2015
Total funding
$95.2M in 8 rounds from 18 investors
By Amgen Ventures
undisclosed deal in Jul, 2005
Total funding
$52M in 2 rounds from 13 investors
By Amgen Ventures
$13.5M Series B in Jan, 2014
Total funding
$29.5M in 1 rounds from 9 investors
By Amgen Ventures
$29.5M Series D in Jan, 2016
Total funding
$43M in 1 rounds from 7 investors
By Amgen Ventures
$43M Series B in Mar, 2016

Want to see the complete list?
Go Pro!